Literature DB >> 31258163

Health Authority Pharmacists' Perceptions of Independent Pharmacist Prescribing.

Mitch Prasad1, Peter S Loewen2, Stephen Shalansky3, Shahrzad Salmasi4, Arden R Barry5.   

Abstract

BACKGROUND: In many jurisdictions, the pharmacist's role continues to evolve from drug distribution-based service delivery to expanded scopes of practice, including independent prescribing of medications.
OBJECTIVES: To assess health authority-based pharmacists' attitudes, beliefs, and perceptions about independent prescribing, to determine how independent prescribing may affect their behaviour, and to identify perceived barriers and enablers to incorporating it into their practice.
METHODS: An anonymous, cross-sectional online survey of 677 health authority-based pharmacists employed by Lower Mainland Pharmacy Services in British Columbia collected information in the following domains: demographic characteristics; attitudes, beliefs, and perceptions regarding pharmacist prescribing; anticipated effect of pharmacist prescribing on behaviour; likelihood of applying for this authority, if granted; and barriers and enablers to applying for prescribing authority and incorporating prescribing into their practice. A multivariate regression analysis was performed.
RESULTS: A total of 266 pharmacists (39.3%) responded to the survey. Most respondents agreed that prescribing is important to the profession and relevant to their practice, and that it might enhance job satisfaction. Additionally, respondents agreed that they had the expertise to prescribe. Respondents perceived prescribing as having the potential to positively affect behaviour, including deprescribing, prescribing at time of discharge or transfer, and renewing medications. Enablers to applying for pharmacist prescribing authority included perceived positive impact on patient care and the profession, level of support from management and coworkers, and personal ability. No barriers were identified. About two-thirds of pharmacists indicated they would likely apply for prescribing authority if it were granted through legislation. Pharmacists with a clinical practice or research role were significantly more likely to apply to be a prescriber, whereas those with more than 10 years of experience were less likely to apply.
CONCLUSIONS: In this study, health authority-based pharmacists held positive attitudes and beliefs about the value and impact of independent prescribing of medications on their practice and the profession. There were no perceived barriers to applying for prescribing authority or to incorporating prescribing into practice.

Entities:  

Keywords:  drug prescriptions; health services; pharmacists; pharmacy; pharmacy research

Year:  2018        PMID: 31258163      PMCID: PMC6592659     

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  21 in total

1.  The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.

Authors:  Ross T Tsuyuki; Yazid N Al Hamarneh; Charlotte A Jones; Brenda R Hemmelgarn
Journal:  J Am Coll Cardiol       Date:  2016-04-04       Impact factor: 24.094

2.  Survey of Alberta hospital pharmacists' perspectives on additional prescribing authorization.

Authors:  Marissa Hutchison; Adrienne Lindblad; Lisa Guirguis; Dale Cooney; Marie Rodway
Journal:  Am J Health Syst Pharm       Date:  2012-11-15       Impact factor: 2.637

3.  Pharmacist-managed culture review service for patients discharged from the emergency department.

Authors:  Julianna Van Enk; Heather Townsend; Jessica Thompson
Journal:  Am J Health Syst Pharm       Date:  2016-09-15       Impact factor: 2.637

4.  Qualitative interviews regarding pharmacist prescribing in the community setting.

Authors:  Michael Feehan; Richard Durante; Jim Ruble; Mark A Munger
Journal:  Am J Health Syst Pharm       Date:  2016-09-15       Impact factor: 2.637

Review 5.  A review of state pharmacist collaborative practice laws.

Authors:  John D Hill; Joseph M Hill; Nicholas J Gentile
Journal:  Am J Health Syst Pharm       Date:  2016-09-15       Impact factor: 2.637

6.  The time has come: Increased prescribing authority for pharmacists.

Authors:  Paul W Abramowitz; Kasey K Thompson; Daniel J Cobaugh
Journal:  Am J Health Syst Pharm       Date:  2016-09-15       Impact factor: 2.637

7.  Lessons learned in updating and improving a state collaborative practice act.

Authors:  Scott J Knoer; Drew D Luder; Joseph M Hill; Thomas S Achey; Antonio Ciaccia
Journal:  Am J Health Syst Pharm       Date:  2016-09-15       Impact factor: 2.637

8.  Drug therapy management in a pharmacist-run stroke prevention clinic.

Authors:  Jennifer Andres; Charles Ruchalski; Paul Katz; Guillermo Linares
Journal:  Am J Health Syst Pharm       Date:  2016-09-15       Impact factor: 2.637

9.  A randomized trial of a community-based approach to dyslipidemia management: Pharmacist prescribing to achieve cholesterol targets (RxACT Study).

Authors:  Ross T Tsuyuki; Meagen Rosenthal; Glen J Pearson
Journal:  Can Pharm J (Ott)       Date:  2016-08-02

10.  Independent prescribing by hospital pharmacists: Patterns and practices in a Canadian province.

Authors:  Taryn Heck; Mary Gunther; Lauren Bresee; Tania Mysak; Chloe Mcmillan; Sheri Koshman
Journal:  Am J Health Syst Pharm       Date:  2015-12-15       Impact factor: 2.637

View more
  2 in total

1.  Perceptions of Independent Pharmacist Prescribing among Health Authority- and Community-Based Pharmacists in Northern British Columbia.

Authors:  Jordan Lewis; Arden R Barry; Katie Bellefeuille; Robert T Pammett
Journal:  Pharmacy (Basel)       Date:  2021-04-23

2.  Increased self-reported pharmacist prescribing during the COVID-19 pandemic: Using the Theoretical Domains Framework to identify barriers and facilitators to prescribing.

Authors:  Amy Grant; Liam Rowe; Natalie Kennie-Kaulbach; Andrea Bishop; Julia Kontak; Sam Stewart; Bobbi Morrison; Ingrid Sketris; Glenn Rodrigues; Laura Minard; Anne Marie Whelan; Lisa Woodill; Elizabeth Jeffers; Judith Fisher; Juanna Ricketts; Jennifer E Isenor
Journal:  Res Social Adm Pharm       Date:  2022-08-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.